What is Novo Nordisk?
'''Novo Nordisk A/S''' is a [[Denmark|Danish]] multinational [[pharmaceutical]] company. It has factories in in nine countries. More than 48,000 people work for the company. Nordisk Insulinlaboratorium was started in 1923 by the Danish [[Nobel Prize|Nobel laureate]] [[August Krogh]], [[pharmacist]] August Kongsted and scientist Hans Christian Hagedorn. It produced [[insulin]]. In 1989 it merged with Novo Industri.<ref>{{Cite web|date=2019-07-08|title=Our History|url=https://www.novonordisk.com/about-novo-nordisk/novo-nordisk-history.html|access-date=2023-03-08|website=web.archive.org|archive-date=2019-07-08|archive-url=https://web.archive.org/web/20190708163754/https://www.novonordisk.com/about-novo-nordisk/novo-nordisk-history.html|url-status=dead}}</ref> 77% of Novo’s voting rights and 28.1% of its shares is owned by the [[Novo Nordisk Foundation]]. It was Europe’s most valuable company in 2023 and dominates the Danish economy. In September 2023 it was worth $421 billion. It plans to buy Inversago Pharma. The [[Wegovy]] weight-loss drug has been very successful.<ref>{{Cite news|last=Kuchler|first=Hannah|date=2023-09-01|title=Novo Nordisk briefly eclipses LVMH as Europe’s most valuable company|work=Financial Times|url=https://www.ft.com/content/97e89e94-38cb-4a22-9a17-c110e39958bc?|access-date=2023-09-02}}</ref> It can cut the risk of [[heart attacks]] by 20% in overweight or [[obese]] patients with [[cardiovascular disease]]. It is expected to sell $7.3 billion in 2024. Ozempic, an injectable form of [[Semaglutide]], is used to treat diabetes. It is expected to sell $16.5 billion in 2024. Lars Fruergaard Jørgensen is the chief executive.<ref>{{Cite web|title=FT Person of the Year: Lars Fruergaard Jørgensen of Novo Nordisk|url=https://www.ft.com/content/d4d289a7-e1a5-4848-8e7e-b592f7018722|access-date=2023-12-19|website=www.ft.com}}</ref> It specialises in [[Diabetes mellitus|diabetes]] care medications and devices. It also does [[hemostasis]] management, [[growth hormone]] therapy and [[hormone